← All trials
NCT05816642
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2022
- Primary completion
- Dec 31, 2023
- Completion date
- Dec 31, 2024
- First posted
- Apr 18, 2023
- Last posted
- Apr 18, 2023
- Enrollment
- 500
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Jiao Tong UniversityLead sponsor
- Huazhong University of Science and TechnologyCollaborator
- Air Force Military Medical University, ChinaCollaborator
- Central South UniversityCollaborator
- Anhui Medical UniversityCollaborator
- Nanjing Medical UniversityCollaborator
- Nanjing UniversityCollaborator
- Shaanxi Provincial People's HospitalCollaborator
- Shanxi Medical UniversityCollaborator
- Sichuan UniversityCollaborator
- Fudan UniversityCollaborator
- Fujian Medical UniversityCollaborator
- Peking UniversityCollaborator
- Wenzhou Medical UniversityCollaborator
- Zhengzhou UniversityCollaborator
- Zhejiang UniversityCollaborator
- Zhejiang UniversityCollaborator
- Zhejiang UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Jiao Tong UniversityCollaborator
- Changzhi Medical CollegeCollaborator
- Sun Yat-Sen UniversityCollaborator
- Nantong UniversityCollaborator
- University of Science and Technology of ChinaCollaborator
- People's Liberation Army of ChinaCollaborator
- People's Liberation Army of ChinaCollaborator
- Chinese Academy of Medical SciencesCollaborator
- Chinese Academy of Medical SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.